Page not found

Search results

  1. Current Request for Proposals

    ... Daiichi Sankyo is seeking novel chemical derivatives (small molecules or peptides) that can be ... will be reviewed for the quality of their scientific content, creativity, and potential for impact at scale. Proposals related to ...

    cttc_admin - 12/13/2023 - 4:47pm

  2. Screening System to Identify 5 Alpha Reductase Inhibitors

    ... goal is to reduce DHT levels in targeted biological systems. Novel inhibitors have the potential to contribute to the development of therapies for ...

    cttc_admin - 12/14/2023 - 7:45am

  3. Novel anti-platelet therapy for treatment of thrombosis, cardiovascular disease, and cerebrovascular injury

    ... thrombosis. Vanderbilt researchers have recently developed novel PAR4 antagonists with potential benefits for patients that minimize ... the market (e.g. vorapaxar, clopidogrel, prasugrel, thrombin inhibitors). To address this unmet clinical need, Vanderbilt researchers have ...

    cttc_admin - 01/23/2024 - 1:42pm

  4. ThermoFisher Scientific - Research Interest Areas

    ... analysis; fluorescent probes for measuring cell health & content; functional flow cytometry reagents; fluorescent assays run on Qubit platform; low-cost cell counting technologies; novel bioconjugation technologies Cell Analysis Instruments ...

    cttc_admin - 01/30/2024 - 12:26pm

  5. La Jolla Pharmaceutical Company and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors

    ... to research and develop small-molecule BMP type-I receptor inhibitors designed to aid in treatment of rare genetic disorders. Below is ... work hard to translate their pioneering discoveries into novel treatments for patients in need.” About La Jolla ...

    steelmk - 10/02/2015 - 10:45am

  6. Vanderbilt Inventor wins ASPET Award

    ... Craig Lindsley's available technologies: Novel PLD Inhibitors Small Molecule Theraputics That Target the ...

    steelmk - 01/13/2017 - 2:44pm

  7. Rethinking drug efficacy: research aims to improve drug development

    ... has potential to facilitate the creation of entirely novel drug categories in the future,” Neuert said. “It also enables the ...

    sommers - 03/11/2024 - 8:54am

  8. Three Vanderbilt technologies earn patent protection in February

    ...  Long Wang 11,897,845  Small Molecule Inhibitors of Lactate Dehydrogenase and Methods of Use Thereof  Ganesha ...  Substituted Phenyl Ethynyl Pyridine Carboxamides as Potent Inhibitors of SARS Virus  Syed Ahmen  Corinne Augelli-Szafran ...

    sommers - 02/29/2024 - 10:29am

  9. Small Molecule-GIRK Potassium Channel Modulators That Are Anxiolytic Therapeutics

    ... are continuing to develop more selective and druggable GIRK inhibitors from different scaffolds. Addressed Need GIRK ... Proof of Concept Tool Compound ML297 Description & Novel features ML297 (VU0456810) is a small molecule compound ...

    cttc_admin - 01/23/2024 - 1:38pm

  10. Innovation Catalyst Fund announces eight inaugural awardees; next round submission deadline is April 15

    ... professor of chemical and biomolecular engineering: “Novel Hydrogel to Improve and Restore Blood Flow to Bone Tissues Through ...

    sommers - 02/13/2024 - 10:43am